Sanara MedTech (SMTI) Total Non-Current Liabilities (2010 - 2026)

Sanara MedTech has reported Total Non-Current Liabilities for 16 years, with the latest figure at $48.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 4.58% year-over-year to $48.6 million; the trailing twelve-month figure through Mar 2026 stood at $48.6 million (up 4.58% YoY), and the FY2025 full-year result was $48.4 million, up 42.78% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $48.6 million, roughly flat from $48.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $48.6 million in Q1 2026, with the low at $187040.0 in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $24.2 million across 5 years, with a median of $18.1 million in 2023.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities tumbled 54.8% — and 2023, when it jumped 4116.63%.
• Sanara MedTech's Total Non-Current Liabilities stood at $6.5 million in 2022, then surged by 138.36% to $15.5 million in 2023, then surged by 118.43% to $33.9 million in 2024, then soared by 42.78% to $48.4 million in 2025, then rose by 0.35% to $48.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $48.6 million (Q1 2026), $48.4 million (Q4 2025), and $47.6 million (Q3 2025), per Business Quant data.